6-33185751-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_080680.3(COL11A2):​c.826G>A​(p.Glu276Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.313 in 1,340,386 control chromosomes in the GnomAD database, including 67,232 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.

Frequency

Genomes: 𝑓 0.33 ( 7530 hom., cov: 24)
Exomes 𝑓: 0.31 ( 59702 hom. )

Consequence

COL11A2
NM_080680.3 missense

Scores

4
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 1.22
Variant links:
Genes affected
COL11A2 (HGNC:2187): (collagen type XI alpha 2 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024698675).
BP6
Variant 6-33185751-C-T is Benign according to our data. Variant chr6-33185751-C-T is described in ClinVar as [Benign]. Clinvar id is 46569.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-33185751-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.375 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A2NM_080680.3 linkc.826G>A p.Glu276Lys missense_variant Exon 6 of 66 ENST00000341947.7 NP_542411.2 P13942A0A0C4DFS1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A2ENST00000341947.7 linkc.826G>A p.Glu276Lys missense_variant Exon 6 of 66 5 NM_080680.3 ENSP00000339915.2 A0A0C4DFS1
COL11A2ENST00000374708.8 linkc.799-697G>A intron_variant Intron 5 of 63 5 ENSP00000363840.4 Q4VXY6
COL11A2ENST00000682718.1 linkn.643G>A non_coding_transcript_exon_variant Exon 5 of 6

Frequencies

GnomAD3 genomes
AF:
0.330
AC:
46741
AN:
141668
Hom.:
7527
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.381
Gnomad AMI
AF:
0.398
Gnomad AMR
AF:
0.298
Gnomad ASJ
AF:
0.382
Gnomad EAS
AF:
0.236
Gnomad SAS
AF:
0.388
Gnomad FIN
AF:
0.245
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.317
Gnomad OTH
AF:
0.343
GnomAD3 exomes
AF:
0.297
AC:
73141
AN:
246010
Hom.:
11550
AF XY:
0.306
AC XY:
41075
AN XY:
134128
show subpopulations
Gnomad AFR exome
AF:
0.367
Gnomad AMR exome
AF:
0.195
Gnomad ASJ exome
AF:
0.372
Gnomad EAS exome
AF:
0.238
Gnomad SAS exome
AF:
0.391
Gnomad FIN exome
AF:
0.212
Gnomad NFE exome
AF:
0.313
Gnomad OTH exome
AF:
0.310
GnomAD4 exome
AF:
0.311
AC:
372581
AN:
1198634
Hom.:
59702
Cov.:
29
AF XY:
0.315
AC XY:
187391
AN XY:
594858
show subpopulations
Gnomad4 AFR exome
AF:
0.390
Gnomad4 AMR exome
AF:
0.197
Gnomad4 ASJ exome
AF:
0.374
Gnomad4 EAS exome
AF:
0.242
Gnomad4 SAS exome
AF:
0.387
Gnomad4 FIN exome
AF:
0.220
Gnomad4 NFE exome
AF:
0.309
Gnomad4 OTH exome
AF:
0.313
GnomAD4 genome
AF:
0.330
AC:
46758
AN:
141752
Hom.:
7530
Cov.:
24
AF XY:
0.329
AC XY:
22398
AN XY:
68050
show subpopulations
Gnomad4 AFR
AF:
0.380
Gnomad4 AMR
AF:
0.298
Gnomad4 ASJ
AF:
0.382
Gnomad4 EAS
AF:
0.235
Gnomad4 SAS
AF:
0.387
Gnomad4 FIN
AF:
0.245
Gnomad4 NFE
AF:
0.317
Gnomad4 OTH
AF:
0.341
Alfa
AF:
0.311
Hom.:
12253
Bravo
AF:
0.318
TwinsUK
AF:
0.315
AC:
1168
ALSPAC
AF:
0.308
AC:
1186
ESP6500AA
AF:
0.367
AC:
1108
ESP6500EA
AF:
0.314
AC:
1703
ExAC
AF:
0.302
AC:
35411
Asia WGS
AF:
0.328
AC:
1141
AN:
3478
EpiCase
AF:
0.315
EpiControl
AF:
0.330

ClinVar

Significance: Benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Glu276Lys in Exon 06 of COL11A2: This variant is not expected to have clinical s ignificance because it has been identified in 36.5% (1108/3032) of African Ameri can chromosomes from a broad population by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS; dbSNP rs9277934). -

Sep 29, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 15, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Otospondylomegaepiphyseal dysplasia, autosomal dominant Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Otospondylomegaepiphyseal dysplasia, autosomal recessive Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Fibrochondrogenesis 2 Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Autosomal recessive nonsyndromic hearing loss 53 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 13 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Stickler Syndrome, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.011
T;T
Eigen
Benign
0.058
Eigen_PC
Benign
0.084
FATHMM_MKL
Uncertain
0.91
D
MetaRNN
Benign
0.0025
T;T
MetaSVM
Benign
-0.52
T
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-0.85
N;N
REVEL
Uncertain
0.31
Sift
Benign
0.66
T;T
Sift4G
Benign
0.75
T;T
Vest4
0.17
ClinPred
0.019
T
GERP RS
3.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs9277934; hg19: chr6-33153528; COSMIC: COSV59496579; COSMIC: COSV59496579; API